Sugi Predict

Sugi Predict / Compounds / SCHEMBL16637008

SCHEMBL16637008

SCHEMBL16637008

O=Cc1c(F)cc(Br)cc1[N+](=O)[O-]

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ERN1 O75460 1/20 0.51
▸ VCAM1 P19320 2/20 0.40
▸ ATM Q13315 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ XDH P47989 1/20 0.39
▸ ALDH1A1 P00352 4/20 0.38
▸ HIF1A Q16665 1/20 0.38
▸ S100A4 P26447 1/20 0.37
▸ TRPV1 Q8NER1 1/20 0.37
▸ MAPT P10636 3/20 0.36
▸ PKM P14618 1/20 0.36
▸ ACLY P53396 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ ALDH5A1 P51649 1/20 0.35
▸ ABAT P80404 1/20 0.35
▸ AKR1B1 P15121 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31423225 1.00 ERN1 (0.51) ERN1VCAM1ATMTDP1XDH
SCHEMBL116056 0.83 ERN1 (0.43) ERN1VCAM1ATMTDP1XDH
SCHEMBL116055 0.83 ERN1 (0.43) ERN1VCAM1ATMTDP1XDH
SCHEMBL27029999 0.79 ERN1 (0.60) ERN1TDP1XDHALDH1A1HIF1A
SCHEMBL20786931 0.79 ERN1 (0.51) ERN1VCAM1TDP1XDHALDH1A1
SCHEMBL31423119 0.79 ERN1 (0.51) ERN1VCAM1XDHALDH1A1S100A4
SCHEMBL22771023 0.79 ERN1 (0.51) ERN1VCAM1XDHALDH1A1S100A4
SCHEMBL20786945 0.79 ERN1 (0.51) ERN1XDHALDH1A1S100A4TRPV1
SCHEMBL16636771 0.78 ERN1 (0.47) ERN1TDP1ALDH1A1HIF1AS100A4
SCHEMBL5430278 0.78 ERN1 (0.44) ERN1VCAM1ATMTDP1XDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12391695-B2 PRMT5 inhibitors LUPIN LIMITED (IN) 2025-08-19 — — US disclosed
US-12234244-B2 Substituted piperazines as inhibitors of KRAS G12C ARAXES PHARMA LLC (US) 2025-02-25 — — US disclosed
US-20240352028-A1 SUBSTITUTED QUINAZOLINES AS INHIBITORS OF KRAS G12C ARAXES PHARMA LLC (US) 2024-10-24 — — US disclosed
US-20240299572-A1 NITROGEN-CONTAINING COMPOUND, CONJUGATE CONTAINING SAID COMPOUND, AND APPLICATION THEREOF Shanghai De Novo Pharmatech Co., Ltd. (CN) 2024-09-12 — — US disclosed
CN-114026094-B PRMT5 inhibitors 印度鲁宾有限公司 2024-06-25 — — CN disclosed
US-11952380-B2 Substituted bicyclic heterocyclic compounds as PRMT5 inhibitors LUPIN LIMITED (IN) 2024-04-09 — — US disclosed
WO-2024067841-A1 BENZAZEPINE DERIVATIVE, CONJUGATE CONTAINING SAME, AND USE THEREOF 上海迪诺医药科技有限公司 2024-04-04 — — WO disclosed
CN-117801107-A Benzazepine derivatives, conjugates containing same and application thereof 上海迪诺医药科技有限公司 2024-04-02 — — CN disclosed
EP-4342884-A1 NITROGEN-CONTAINING COMPOUND, CONJUGATE CONTAINING SAID COMPOUND, AND APPLICATION THEREOF Shanghai de Novo Pharmatech Co., Ltd. (CN) 2024-03-27 — — EP disclosed
US-20240043441-A1 INHIBITORS OF KRAS G12C ARAXES PHARMA LLC (US) 2024-02-08 — — US disclosed
US-20180118757-A1 SUBSTITUTED QUINAZOLINES AS INHIBITORS OF KRAS G12C ARAXES PHARMA LLC 2018-05-03 — — US disclosed
US-9840516-B2 Substituted quinazolines as inhibitors of KRAS G12C ARAXES PHARMA LLC (US) 2017-12-12 — — US disclosed
US-9840516-B2 Substituted quinazolines as inhibitors of KRAS G12C ARAXES PHARMA LLC (US) 2017-12-12 — — US disclosed
US-9840516-B2 Substituted quinazolines as inhibitors of KRAS G12C ARAXES PHARMA LLC (US) 2017-12-12 — — US disclosed
EP-3055290-A1 INHIBITORS OF KRAS G12C Araxes Pharma LLC (US) 2016-08-17 — — EP disclosed
US-20150239900-A1 INHIBITORS OF KRAS G12C ARAXES PHARMA LLC 2015-08-27 — — US disclosed
US-20150239900-A1 INHIBITORS OF KRAS G12C ARAXES PHARMA LLC 2015-08-27 — — US disclosed
US-20150239900-A1 INHIBITORS OF KRAS G12C ARAXES PHARMA LLC 2015-08-27 — — US disclosed
WO-2015054572-A1 INHIBITORS OF KRAS G12C ARAXES PHARMA LLC (US) 2015-04-16 — — WO disclosed
WO-2015054572-A1 INHIBITORS OF KRAS G12C ARAXES PHARMA LLC (US) 2015-04-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12234244-B2 Substituted piperazines as inhibitors of KRAS G12C KRAS, NRAS, HRAS ERN1 2526/4885VCAM1 4575/4885ATM 2658/4885
US-12391695-B2 PRMT5 inhibitors PRMT5, PRMT1, PRMT3 ERN1 695/4885VCAM1 2750/4885ATM 632/4885
US-20240299572-A1 NITROGEN-CONTAINING COMPOUND, CONJUGATE CONTAINING SAID COMPOUND, AND APPLICATION THEREOF TLR8, TLR9, TLR7 ERN1 3050/4885VCAM1 834/4885ATM 1736/4885
US-20240352028-A1 SUBSTITUTED QUINAZOLINES AS INHIBITORS OF KRAS G12C KRAS, NRAS, HRAS ERN1 1177/4885VCAM1 4687/4885ATM 983/4885
US-20180118757-A1 SUBSTITUTED QUINAZOLINES AS INHIBITORS OF KRAS G12C KRAS, NRAS, HRAS ERN1 1177/4885VCAM1 4687/4885ATM 983/4885
US-20150239900-A1 INHIBITORS OF KRAS G12C KRAS, NRAS, HRAS ERN1 973/4885VCAM1 4440/4885ATM 1258/4885
US-11952380-B2 Substituted bicyclic heterocyclic compounds as PRMT5 inhibitors PRMT5, PRMT1, PRMT3 ERN1 1433/4885VCAM1 3759/4885ATM 769/4885
US-20240043441-A1 INHIBITORS OF KRAS G12C KRAS, NRAS, HRAS ERN1 973/4885VCAM1 4440/4885ATM 1258/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.